Spermidine Associated with Gut Microbiota Protects Against MRSA Bloodstream Infection by Promoting Macrophage M2

Qingqing Li1,2, Ping Tian1,2, Mingjuan Guo3

  • 1Department of Infectious Diseases & Anhui Center for Surveillance of Bacterial Resistance, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.

ACS Infectious Diseases
|October 9, 2024
PubMed

Insights

Spermidine protects against Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections by reducing bacteria and inflammation. It shifts macrophages to an anti-inflammatory state, potentially through PTPN2, improving survival.

Area of Science:

  • Microbiology
  • Immunology
  • Metabolomics

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen.
  • Gut microbiota metabolites, like spermidine, influence infectious diseases.
  • Spermidine's immunomodulatory role in MRSA bloodstream infection is not fully understood.

Purpose of the Study:

  • To investigate the protective effects and mechanisms of spermidine in MRSA-induced bloodstream infection.

Main Methods:

  • Animal model of MRSA bloodstream infection.
  • Assessment of bacterial load and inflammatory markers.
  • Macrophage phenotype analysis.
  • Protein tyrosine phosphatase nonreceptor 2 (PTPN2) expression analysis.

Main Results:

  • Spermidine administration reduced MRSA bacterial load and inflammatory factor expression.
  • Spermidine promoted a shift towards an anti-inflammatory macrophage phenotype.
  • Elevated protein tyrosine phosphatase nonreceptor 2 (PTPN2) expression was observed.
  • Spermidine treatment prolonged survival in infected mice.

Conclusions:

  • Spermidine exhibits protective effects against MRSA bloodstream infection.
  • The mechanism involves shifting macrophage phenotype and potentially upregulating PTPN2.
  • Spermidine offers a potential therapeutic strategy for MRSA infections.